Hanson & Doremus Investment Management
Position in GILD — Gilead Sciences, Inc.
CIK 1393944
BURLINGTON, VT
Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$296,140
-$30,543 QoQ
Shares Held
2,344
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,657
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hanson & Doremus Investment Management holds $28,323,234 across 13 Drug Manufacturers - General names. GILD ranks #10 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
56,094 | $7,208,079 | |
| 2 | LLY |
ELI LILLY & Co
|
3,655 | $4,383,917 | |
| 3 | ABBV |
AbbVie Inc.
|
16,581 | $4,172,442 | |
| 4 | JNJ |
Johnson & Johnson
|
16,303 | $4,140,472 | |
| 5 | AMGN |
Amgen Inc
|
10,917 | $3,953,264 | |
| 6 | AZN |
Astrazeneca PLC
|
5,916 | $1,121,791 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
18,157 | $1,046,206 | |
| 8 | PFE |
Pfizer Inc
|
35,388 | $852,143 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $296,140 | 2,344 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $326,683 | 2,344 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $275,428 | 2,244 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $250,416 | 2,256 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $304,227 | 2,744 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $307,465 | 2,744 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $22,538 | 244 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $20,456 | 244 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $25,317 | 369 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $162,322 | 2,216 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $169,391 | 2,091 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $156,699 | 2,091 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $157,299 | 2,041 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $169,341 | 2,041 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $175,219 | 2,041 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $125,909 | 2,041 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $180,299 | 2,917 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $193,628 | 3,257 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $306,341 | 4,219 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $338,562 | 4,847 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $392,295 | 5,697 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $377,309 | 5,838 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $338,024 | 5,802 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $359,993 | 5,697 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $445,251 | 5,787 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $445,345 | 5,957 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||